DO JUNIOR DOCTORS PRESCRIBE DISEASE MODIFYING ANTI RHEUMATIC DRUGS SAFELY?

被引：0
|
作者：
Nisar, M. K. [1 ]
Weller, H. [1 ]
机构：
[1] Luton & Dunstable Univ Hosp, Rheumatol, Luton, Beds, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.1691
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0592
引用
收藏
页码：430 / 430
页数：1
相关论文
共 50 条
  • [1] DISEASE-MODIFYING ANTI-RHEUMATIC DRUG PRESCRIPTION AND JUNIOR DOCTORS: IS IT SAFE?
    Weller, Hannah
    Nisar, Muhammad K.
    RHEUMATOLOGY, 2017, 56 : 193 - 193
  • [2] Drugs acting on the central nervous system: do foundation doctors prescribe safely?
    Beardon, K.
    Sharma, N.
    Maxwell, S.
    9TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS - EACPT, 2009, : 11 - +
  • [3] DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    STECHER, VJ
    CARLSON, JA
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 1983, 18 : 171 - 179
  • [4] Which non-technical skills do junior doctors require to prescribe safely? A systematic review
    Dearden, Effie
    Mellanby, Edward
    Cameron, Helen
    Harden, Jeni
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (06) : 1303 - 1314
  • [5] Disease-modifying anti-rheumatic drugs: do they reduce cardiac complications of RA?
    Hamdulay, Shahir S.
    Mason, Justin C.
    HEART, 2009, 95 (18) : 1471 - 1472
  • [6] Disease-modifying anti-rheumatic drugs - Cyclosporin
    Chaudhuri, K
    Torley, H
    Madhok, R
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (09): : 1016 - 1021
  • [7] Pharmacogenetics of disease-modifying anti-rheumatic drugs
    Tanaka, E
    Taniguchi, A
    Urano, W
    Yamanaka, H
    Kamatani, N
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (02): : 233 - 247
  • [8] Disease Modifying Anti-Rheumatic Drugs Compliance Study
    Vostretsova, Kateryna
    Rogers, Pam
    Thompson, Darby J. S.
    Lacaille, Diane
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S731 - S732
  • [9] How do clinicians prescribe bridging glucocorticoids in people starting or escalating disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a service evaluation survey
    Prior, James A.
    Roddy, Edward
    Solis-Trapala, Ivonne
    Cornwall, Nicola
    Jinks, Clare
    Abhishek, Abhishek
    Bukhari, Marwan
    Galloway, James
    Goodson, Nicola
    Jowett, Sue
    Hider, Samantha
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2023, 7 (03)
  • [10] DO RHEUMATHOLOGISTS APPLY THE SAME EFFICACY CRITERIA TO ALL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS?
    Gonzalez-Alvaro, I.
    Carmona, L.
    Balsa, A.
    Belmonte, M. A.
    Sanmarti, R.
    Tena, X.
    RHEUMATOLOGY, 2002, 41 : 44 - 44
12345